A standard numbering scheme has been proposed for class C β-lactamases. This will significantly enhance comparison of biochemical and biophysical studies performed on different members of this class of enzymes and facilitate communication in the field.
KEYWORDS: beta-lactamases
ABSTRACT
A standard numbering scheme has been proposed for class C β-lactamases. This will significantly enhance comparison of biochemical and biophysical studies performed on different members of this class of enzymes and facilitate communication in the field.
TEXT
β-Lactamases hydrolyze β-lactam antibiotics, such as penicillins, cephalosporins, and carbapenems, rendering them inactive, and thus, they represent one of the most important mechanisms of bacterial resistance toward these agents (1). These enzymes have been classified according to substrate and inhibitor specificity (1–3) and according to their primary protein sequence (4). Four molecular classes are generally recognized, A, B, C, and D (5): enzymes in classes A, C, and D have a serine residue in the catalytic center that is activated by neighboring residues, and perhaps a substrate moiety, to carry out nucleophilic attack on the carbonyl moiety of the β-lactam, forming an acyl ester at rates that approach limitation by the rate of diffusion (6, 7). The acyl ester is subsequently hydrolyzed by a water molecule, also activated by residues in the catalytic center, at a lower rate that may be governed by rearrangement of the enzyme complex (8–10). The three classes of serine enzymes differ in their molecular structures and in mechanisms of carrying out the hydrolysis of the acyl ester (11).
The class C β-lactamases comprise the second most abundant group of enzymes and are found solely in Gram-negative bacteria, especially members of the Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter species (1, 12). Although they were originally identified as chromosomally encoded, more recently, genes encoding class C enzymes have been found mobilized on plasmids in the Enterobacteriaceae (13). The class C enzymes fall into group 1 of the Bush-Jacoby-Medeiros functional classification and are recognized as cephalosporinases because of the high turnover numbers exhibited by many of the members of this class for first- and second-generation cephalosporins and cephamycins. The catalytic efficiency (kcat/Km) is, however, rather similar for penicillins, for which many of the enzymes have high apparent affinities (low Km) but correspondingly low turnover numbers. The enzymes in this class generally exhibit low turnover numbers for third-generation cephalosporins and very low turnover numbers for monobactams and carbapenems, although they react readily with these agents to form rather stable acyl-enzyme intermediates (14). Despite the low turnover, the enzymes can still afford protection against these agents, partly because the enzymes can be expressed to very high levels in the periplasmic space of Gram-negative bacteria, where they may act as a sink, trapping the antibiotic before it can reach its lethal target, and partly because the resistant bacteria have acquired additional mechanisms of resistance that restrict the net influx of the antibiotic (15). These additional mechanisms can involve mutation of residues in the outer membrane porins (16), mutations in regulatory systems that result in low expression of these proteins, and loss of the porin genes, as well as mutations in the tripartite RND family efflux systems, or their regulatory systems, that result in increased activity of these pumps (17, 18).
The mechanism by which the class C enzymes hydrolyze β-lactam antibiotics is still incompletely understood. From the crystal structure of the complex formed between aztreonam and the Citrobacter freundii chromosomal enzyme, it has been concluded that a tyrosine residue in the catalytic center acts a general base during hydrolysis, activating both the serine residue for attack on the β-lactam nucleus and a water molecule for attack on the ester bond formed between the serine and the lactam moiety (19). Subsequently, further complexes of class C enzymes from different species with a variety of substrates and inhibitors have become available, shedding further light on the details of the acylation mechanism (14). Additional studies using site-directed mutagenesis to explore the contributions of selected residues in and around the catalytic center have added further understanding of the mechanism (20–25). Kinetic studies, including time-resolved Fourier-transform infrared spectroscopy studies, have shown that there are significant conformational changes during the catalytic cycle, changes that are not obvious in the time frame of the crystallographic studies (9, 10).
Bringing these disparate studies together requires a consistent frame of reference: the studies on isolated proteins will have residue numbers starting from the first amino acid in the primary sequence of the isolated protein, whereas genetic studies may refer to numbers starting from the first codon in the translated gene sequence (26, 27) and these may differ from numbering derived from multiple sequence alignment of naturally occurring variants within a species (28). There is therefore an urgent need to address the inconsistencies between numbering of amino acid residues in different studies on the same enzyme. Despite the class C enzyme from Escherichia coli being the first β-lactamase to be recorded (29), the nomenclature of this group has lagged behind advances in nomenclature in other families (30). Workers studying the class A β-lactamases have benefitted for nearly 3 decades from a unified standard numbering scheme that fixes the positions of certain important residues and allows for insertion or deletion of residues at other positions in the sequence (5), and an analogous scheme for numbering residues of class B enzymes was proposed nearly 20 years ago (31). In this issue, Andrew Mack and colleagues (32) present a similar standard numbering system for the class C β-lactamase family. The proposal is based on multiple sequence alignment of 32 sequences of class C enzymes, including both chromosomal and plasmid-encoded proteins, and derivation of a consensus secondary structure map from the 10 class C β-lactamases for which an X-ray crystal structure in available in the Protein Data Bank. The proposed amino acid numbering system is based on the sequence of Enterobacter cloacae P99 and keeps the widely followed conventional numbering of the important residues in the catalytic center: serine 64, lysine 67, tyrosine 150, and lysine 315. In the proposed scheme, any insertions relative to the reference sequence are denoted by appending a lowercase letter (e.g., “a”) to the number of the residue immediately preceding the insertion, while any deletions are skipped (e.g., ACC-1 has the sequence G115 followed by L117 due to an apparent deletion at position 116 in comparison to the reference sequence). For mature enzymes that are longer than the reference sequence, the first residue of an N-terminal extension is denoted “0” and any further extension is denoted by adding a lowercase letter (e.g., “a”), while any additional residues at the C terminus are assigned increasing numbers. Residues in signal peptides are identified by negative numbers starting with −1 at the (predicted) cleavage site and decreasing toward the N terminus of the peptide. Examples illustrating the application of these very logical rules are given in the article. The authors suggest that the standard numbering scheme should be used in biochemical and biophysical publications but that the usual convention of starting at residue 1 for the signal sequence should be followed in genetic and epidemiological studies. The adoption of this standard numbering will considerably reduce complications in communication in the field and is to be much encouraged.
The views expressed in this article do not necessarily reflect the views of the journal or of ASM.
REFERENCES
- 1.Richmond MH, Sykes RB. 1973. The beta-lactamases of Gram-negative bacteria and their possible physiological role. Adv Microb Physiol 9:31–88. doi: 10.1016/s0065-2911(08)60376-8. [DOI] [PubMed] [Google Scholar]
- 2.Bush K, Jacoby GA, Medeiros AA. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 39:1211–1233. doi: 10.1128/aac.39.6.1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Bush K, Jacoby GA. 2010. Updated functional classification of β-lactamases. Antimicrob Agents Chemother 54:969–976. doi: 10.1128/AAC.01009-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Ambler RP. 1980. The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci 289:321–331. doi: 10.1098/rstb.1980.0049. [DOI] [PubMed] [Google Scholar]
- 5.Ambler RP, Coulson AF, Frère JM, Ghuysen JM, Joris B, Forsman M, Levesque RC, Tiraby G, Waley SG. 1991. A standard numbering scheme for the class A β-lactamases. Biochem J 276:269–270. doi: 10.1042/bj2760269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Matagne A, Lamotte-Brasseur J, Frère JM. 1998. Catalytic properties of class A β-lactamases: efficiency and diversity. Biochemistry J 330:581–598. doi: 10.1042/bj3300581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Page MGP. 1993. The kinetics of non-stoichiometric bursts of β-lactam hydrolysis ctalaysed by class C β-lactamases. Biochem J 295:295–304. doi: 10.1042/bj2950295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Heinze-Krauss I, Angehrn P, Charnas RL, Gubernator K, Gutknecht EM, Hubschwerlen C, Kania M, Oefner C, Page MG, Sogabe S, Specklin JL, Winkler F. 1998. Structure-based design of β-lactamase inhibitors. I. Synthesis and evaluation of bridged monobactams. J Med Chem 41:3961–3971. doi: 10.1021/jm980023c. [DOI] [PubMed] [Google Scholar]
- 9.Wilkinson AS, Ward S, Kania M, Page MGP, Wharton CW. 1999. Multiple conformations of the acylenzyme formed in the hydrolysis of methicillin by Citrobacter freundii β-lactamase: a time-resolved FTIR spectroscopic study. Biochemistry 38:3851–3856. doi: 10.1021/bi990030i. [DOI] [PubMed] [Google Scholar]
- 10.Wilkinson AS, Bryant PK, Meroueh SO, Page MGP, Mobashery S, Wharton CW. 2003. A dynamic structure for the acyl-enzyme species of the antibiotic aztreonam with the Citrobacter freundii β-lactamase revealed by infrared spectroscopy and molecular dynamics simulations. Biochemistry 42:1950–1957. doi: 10.1021/bi0266941. [DOI] [PubMed] [Google Scholar]
- 11.Waley SG. 1992. β-Lactamase: mechanism of action, p 198–228. In Page MI. (ed), The chemistry of β-lactams. Blackie Academic & Professional, London, United Kingdom. [Google Scholar]
- 12.Jacoby GA. 2009. AmpC β-lactamases. Clin Microbiol Rev 22:161–182. doi: 10.1128/CMR.00036-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Philippon A, Arlet G, Jacoby GA. 2002. Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother 46:1–11. doi: 10.1128/aac.46.1.1-11.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Bauvois C, Wouters J. 2007. Crystal structures of class C β-lactamases: mechanistic implications and perspectives for drug design, p 145–161. In Bonomo RA, Tolmasky ME (ed), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination and perspectives for inhibition. ASM Press, Washington, DC. [Google Scholar]
- 15.Nikaido H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67:593–656. doi: 10.1128/MMBR.67.4.593-656.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Bajaj H, Scorciapino MA, Moynié L, Page MG, Naismith JH, Ceccarelli M, Winterhalter M. 2016. Molecular basis of filtering carbapenems by porins from β-lactam-resistant clinical strains of Escherichia coli. J Biol Chem 291:2837–2847. doi: 10.1074/jbc.M115.690156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Fernàndez L, Hancock RE. 2012. Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin Microbiol Rev 25:661–681. doi: 10.1128/CMR.00043-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Blair JM, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJ. 2015. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol 13:42–51. doi: 10.1038/nrmicro3380. [DOI] [PubMed] [Google Scholar]
- 19.Oefner C, D'Arcy A, Daly JJ, Gubernator K, Charnas RL, Heinze I, Hubschwerlen C, Winkler FK. 1990. Refined crystal structure of β-lactamase from Citrobacter freundii indicates a mechanism for β-lactam hydrolysis. Nature 343:284–288. doi: 10.1038/343284a0. [DOI] [PubMed] [Google Scholar]
- 20.Tsukamoto K, Tachibana K, Yamazaki N, Ishii Y, Ujiie K, Nishida N, Sawai T. 1990. Role of lysine-67 in the active site of class C β-lactamase from Citrobacter freundii GN346. Eur J Biochem 188:15–22. doi: 10.1111/j.1432-1033.1990.tb15365.x. [DOI] [PubMed] [Google Scholar]
- 21.Tsukamoto K, Nishida N, Tsuruoka M, Sawai T. 1990. Function of the conserved triad residues in the class C β-lactamase from Citrobacter freundii GN346. FEBS Lett 271:243–246. doi: 10.1016/0014-5793(90)80416-G. [DOI] [PubMed] [Google Scholar]
- 22.Dubus A, Monnaie D, Jacobs C, Normark S, Frère JM. 1993. A dramatic change in the rate-limiting step of β-lactam hydrolysis results from the substitution of the active-site serine residue by a cysteine in the class-C β-lactamase of Enterobacter cloacae 908R. Biochem J 292:537–543. doi: 10.1042/bj2920537. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Dubus A, Normark S, Kania M, Page M. 1994. The role of tyrosine 150 in catalysis of β-lactam hydrolysis by Escherichia coli AmpC β-lactamase investigated by site-directed mutagenesis. Biochemistry 33:8577–8586. doi: 10.1021/bi00194a024. [DOI] [PubMed] [Google Scholar]
- 24.Monnaie D, Dubus A, Cooke D, Marchand J, Normark S, Frère JM. 1994. Role of residue Lys315 in the mechanism of action of the Enterobacter cloacae 908R β-lactamase. Biochemistry 33:5193–5201. doi: 10.1021/bi00183a024. [DOI] [PubMed] [Google Scholar]
- 25.Dubus A, Normark S, Kania M, Page M. 1995. Role of asparagine 152 in catalysis of β-lactam hydrolysis by Escherichia coli AmpC β-lactamase studied by site-directed mutagenesis. Biochemistry 34:7757–7764. doi: 10.1021/bi00023a023. [DOI] [PubMed] [Google Scholar]
- 26.Rodriguez-Martinez JM, Poirel L, Nordmann P. 2009. Extended-spectrum cephalosporinases in Pseudomonas aeruginosa. Antimicrob Agents Chemother 53:1766–1771. doi: 10.1128/AAC.01410-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Berrazeg M, Jeannot K, Ntsogo Enguéné VY, Broutin I, Loeffert S, Fournier D, Plésiat P. 2015. Mutations in β-lactamase AmpC increase resistance of Pseudomonas aeruginosa isolates to antipseudomonal cephalosporins. Antimicrob Agents Chemother 59:6248–6255. doi: 10.1128/AAC.00825-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Drawz SM, Taracila M, Caselli E, Prati F, Bonomo RA. 2011. Exploring sequence requirements for C3/C4 carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: insights into plasticity of AmpC β-lactamase. Protein Sci 20:941–958. doi: 10.1002/pro.612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Abraham EP, Chain E. 1940. An enzyme from bacteria able to destroy penicillin. Nature 146:837–837. doi: 10.1038/146837a0. [DOI] [PubMed] [Google Scholar]
- 30.Bush K. 2013. The ABCD’s of β-lactamase nomenclature. J Infect Chemother 19:549–559. doi: 10.1007/s10156-013-0640-7. [DOI] [PubMed] [Google Scholar]
- 31.Galleni M, Lamotte-Brasseur J, Rossolini GM, Spencer J, Dideberg O, Frère JM, The Metallo- β-Lactamase Working Group . 2001. Standard numbering scheme for class B β-lactamases. Antimicrob Agents Chemother 45:660–663. doi: 10.1128/AAC.45.3.660-663.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Mack AR, Barnes MD, Taracila MA, Hujer AM, Hujer KM, Cabot G, Feldgarden M, Haft DH, Klimke W, van den Akker F, Vila AJ, Smania A, Haider S, Papp-Wallace KM, Bradford PA, Rossolini GM, Docquier J-D, Frère JM, Galleni M, Hanson ND, Oliver A, Plésiat P, Poirel L, Nordmann P, Palzkill TG, Jacoby GA, Bush K, Bonomo RA. 2020. A standard numbering scheme for class C β-lactamases. Antimicrob Agents Chemother 64:e01841-19. doi: 10.1128/AAC.01841-19. [DOI] [PMC free article] [PubMed] [Google Scholar]